Sign in →

TEST ID INHB Inhibin B, Serum

Reporting Name

Inhibin B, S

Specimen Type

Serum


Ordering Guidance


For the initial evaluation of patients suspected of having a granulosa cell tumor of the ovary, order INHAB / Inhibin A and B, Tumor Marker, Serum. If the results of the profile show that either inhibin A or B are elevated, consider monitoring the patient with the individual tests, INHA / Inhibin A, Tumor Marker, Serum or INHB / Inhibin B, Serum.



Specimen Required


Supplies: Sarstedt Aliquot Tube 5 mL (T914)

Collection Container/Tube:

Preferred: Serum gel

Acceptable: Red top

Submission Container/Tube: Plastic vial

Specimen Volume: 0.5 mL

Collection Instructions: Centrifuge and aliquot serum into a plastic vial.


Specimen Minimum Volume

0.4 mL

Specimen Stability Information

Specimen Type Temperature Time Special Container
Serum Refrigerated (preferred) 14 days
  Frozen  90 days
  Ambient  7 days

Method Name

Enzyme-Linked Immunosorbent Assay (ELISA)

Reject Due To

Gross hemolysis Reject
Gross lipemia OK
Gross icterus OK

Reference Values

Males

<15 days: 68-373 pg/mL

15-180 days: 42-516 pg/mL

6 months-7 years: 24-300 pg/mL

8-30 years: 47-383 pg/mL

31-72 years: <358 pg/mL

>72 years: Not established

 

Females

≤12 years: <183 pg/mL

13-41 years Regular Cycle (Follicular Phase): <224 pg/mL

42-51 years Regular Cycle (Follicular Phase): <108 pg/mL

13-51 years Regular Cycle (Luteal Phase): <80 pg/mL

>51 years (Postmenopausal): <12 pg/mL

Day(s) Performed

Monday, Wednesday, Friday

Report Available

2 to 4 days

Specimen Retention Time

3 months

Performing Laboratory

Mayo Clinic Laboratories in Rochester

CPT Code Information

83520

Forms

If not ordering electronically, complete, print, and send an Oncology Test Request (T729) with the specimen.

Useful For

Aiding in the diagnosis of granulosa cell tumors and mucinous epithelial ovarian tumors

 

Monitoring of patients with granulosa cell tumors and epithelial mucinous-type tumors of the ovary known to overexpress inhibin B

 

As an adjunct to follicle-stimulating hormone testing during infertility evaluation